David Erritzoe
Researcher
Faculty of Medicine
National Heart Lung Institute
United Kingdom
Biography
Post-doctoral Researcher and Academic Clinical Fellow, Centre for Neuropsychopharmacology, Division of Brain Sciences, Imperial College London. Involved in several lines of psychopharmacological and brain imaging research at Imperial; investigating dopaminergic neurotransmission with measurements of the dopamine D3 receptor in alcohol addiction, studies of opioid neurotransmission in pathological gambling, and functional imaging studies looking at the role of dopamine D3 and mu-opiate receptors in cocaine, alcohol, and heroin addiction. In addition, together with Prof Nutt and Dr Carhart-Harris conducting brain imaging of the acute effects of MDMA and psychedelic compounds.
Research Interest
pharmacology
Publications
-
Carhart-Harris RL, Murphy K, Leech R, et al., 2015, The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level-Dependent Resting State Functional Connectivity, Biological Psychiatry, Vol:78, ISSN:0006-3223, Pages:554-562
-
Mick I, Myers J, Ramos AC, et al., 2016, Blunted Endogenous Opioid Release Following an Oral Amphetamine Challenge in Pathological Gamblers, Neuropsychopharmacology, Vol:41, ISSN:0893-133X, Pages:1742-1750
